Tethis: Tethis: 15 Million Raised For Developing Diagnostic Methods In Oncology With Liquid Biopsy

Enea TECH and Biomedical Foundation announced a €15 million investment in Tethis S.p.A., a Milan-based company at the forefront of cancer diagnostics. This new round follows previous investments from Genextra and Indaco Venture Partners. The post Tethis: €15 Million Raised For Developing Diagnostic Methods In Oncology With Liquid Biopsy appeared first on Pulse 2.0.